Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to ...

Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.

Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.

In dogs with pancreatitis, the digestive enzymes don’t flow to the intestines to digest food as they should but instead start ...

Glucagon-like peptide 1 ... reports of some patients experiencing nasty side effects, such as persistent vomiting and stomach paralysis. Additionally, a large study published in 2025 revealed ...

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Linda Gigliotti, MS, RDN, CDCES, FAND, about combining the use of GLP-1 ...

Serious hypersensitivity reactions have been reported with glucagon, including generalized ... for Gvoke in adult patients were nausea, vomiting, injection site edema raised 1 mm or greater ...

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...